Cargando…
Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression
Extensive research has demonstrated a tumor‐promoting role of increased WNT5A expression in malignant melanoma. However, very little light has been shed upon how WNT5A expression is up‐regulated in melanoma. A potential regulator of WNT5A expression is the pro‐inflammatory cytokine Interleukin (IL)‐...
Autores principales: | Linnskog, Rickard, Jönsson, Gunilla, Axelsson, Lena, Prasad, Chandra P., Andersson, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528610/ https://www.ncbi.nlm.nih.gov/pubmed/24954857 http://dx.doi.org/10.1016/j.molonc.2014.05.008 |
Ejemplares similares
-
Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion
por: Linnskog, Rickard, et al.
Publicado: (2016) -
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015) -
WNT‐5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
por: Prasad, Chandra Prakash, et al.
Publicado: (2013) -
Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells
por: Mohapatra, Purusottam, et al.
Publicado: (2019) -
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
por: Canesin, Giacomo, et al.
Publicado: (2017)